Veracyte Labs SD Corporation
San Diego, CA Decipher Biosciences, Inc. Part of Veracyte, Inc.
- UEI
- DKKCNLTYT2A1
- CAGE
- 805R8
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Veracyte, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
South San Francisco, CA
JS7GBP6LCMN6
-
Parent
South San Francisco, CA
JS7GBP6LCMN6
- SAM.gov registration date
- Physical address
- 6925 Lusk Blvd #200, San Diego, CA 92121, USA
- Website
- veracyte.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $194,435 |
| FY2026 | $1,188,183 |
| FY2025 | $616,329 |
| FY2024 | $689,698 |
| FY2023 | $957,751 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,267,814 | |
| 2 | Defense Health Agency | $114,805 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mdxhealth, Inc. | Irvine, CA | 621511 Medical Laboratories |
| Exact Sciences Laboratories, LLC | Madison, WI | 621511 Medical Laboratories |
| Genomic Health, Inc. | Redwood City, CA | 621511 Medical Laboratories |
| Biotheranostics Inc. | San Diego, CA | 621511 Medical Laboratories |
| Neogenomics Laboratories, Inc. | Fort Myers, FL | 541380 Testing Laboratories and Services |
About the company
Veracyte Labs SD Corporation, operating as the Decipher Biosciences, Inc. Division, supplies proprietary genomic prostate cancer diagnostic testing services to the Department of Veterans Affairs and the Defense Health Agency as a prime contractor on GSA Schedule 621-II medical laboratory vehicles, competing full-and-open with no set-aside designations.
Veracyte Labs SD is a for-profit subsidiary of Veracyte, Inc., headquartered in South San Francisco, with operations in San Diego, California. The division's sole federal capability centers on the Decipher Prostate Cancer Test, a genomic classifier that analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential, enabling clinicians to support precision medicine treatment decisions for veteran and military healthcare beneficiaries. All 44 awards in the federal footprint reflect this single, specialized service line — no diversification into other cancer types, allied diagnostics, or ancillary services appears in the award record. The vendor competes exclusively on full-and-open vehicles with no small business set-asides; the specialized and proprietary nature of its genomic testing capabilities has enabled sole-source justifications across multiple contract awards.
Customer concentration sits heavily within the Veterans Health Administration's regional service networks. The top five customers by award count — VISN 17, VISN 21, VISN 1, VISN 8, and VISN 10 — account for 75% of awards (33 of 44). However, the dollar picture diverges sharply: a single award from VISN 12 carries $10.9 million in combined potential value, anchoring 83% of the portfolio's $24.4 million ceiling. VISN 8 ($3.5 million), VISN 1 ($3 million), VISN 21 ($1.4 million), and the VA Strategic Acquisition Center Frederick ($1.3 million) round out the top five by potential value. The Defense Health Agency has placed a smaller footprint — two delivery orders and one IDC worth roughly $340 thousand combined — but represents growth into the military healthcare space beyond VA networks.
Vehicle position is monolithic: 43 task orders sit under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), with the remaining awards distributed across three smaller IDCs (36C26120D0064, W81K0224D0013, and BPA 36C25926A0015). The vendor holds five single-award blanket purchase agreements and indefinite delivery contracts as master vehicles: VISN 1 ($1.95 million ceiling, through January 2028), VISN 8 ($972 thousand, through January 2028), VISN 17 ($991 thousand, through November 2026), Defense Health Agency ($194 thousand, through September 2026), and VISN 2 ($486 thousand, through May 2027). Task orders against these masters range from $3,240 to $1.62 million, with recent awards (late 2025 to mid-2026) skewing toward larger delivery orders ($648 thousand to $1.62 million) over smaller BPA calls, suggesting shift toward longer-term, higher-volume commitments.
Activity has grown unevenly: three awards in 2022, nine in 2023, six in 2024, nine in 2025, and five so far in 2026. Eight awards (combined potential value $1.2 million) reach ultimate completion within the next twenty-four months, creating modest recompete exposure. The vendor has obligated only $5.8 million of its $24.4 million combined potential value ceiling (24%), indicating substantial unexercised capacity across existing vehicles, particularly within the two largest master BPAs with VISN 1 and VISN 8. The footprint reflects no subcontractor awards — all 44 awards are prime positions.
NAICS concentration is absolute: 44 awards under Medical Laboratories (NAICS 621511). Primary Service Code work splits across Reference Laboratory Testing (33 awards), Laboratory Equipment and Supplies (5 awards), and In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (4 awards), all aligned to the single Decipher test offering. This category depth signals tight market positioning: the vendor is a specialized, sole-source provider with no adjacent service lines, making it a competitive threat only on prostate cancer genomic testing vehicles and a limited teaming opportunity for larger federal IT or systems integrators seeking diagnostic sub-capacity.
Quick answers
Is Veracyte Labs SD Corporation registered in SAM.gov?
Yes. Veracyte Labs SD Corporation's SAM.gov registration is active through August 24, 2027.
What is Veracyte Labs SD Corporation's CAGE code?
Veracyte Labs SD Corporation's CAGE code is 805R8, and its Unique Entity ID (UEI) is DKKCNLTYT2A1.
Which contract vehicles does Veracyte Labs SD Corporation hold?
Veracyte Labs SD Corporation holds a place on 1 federal contract vehicle: FSS-621-II.
How much has Veracyte Labs SD Corporation received in federal contracts?
Federal contracts obligated $616,329 to Veracyte Labs SD Corporation in fiscal year 2025 and $3,646,397 in fiscal years 2023 through 2027.
How does Veracyte Labs SD Corporation rank among federal contractors?
Veracyte Labs SD Corporation's parent company, Veracyte, Inc., ranked #31 in NAICS 621511, #41 in PSC Q515 and #43 in NAICS 6215 in FY2025.
What is Veracyte Labs SD Corporation's most recent federal award?
Veracyte Labs SD Corporation's most recent federal contract award is WRJ task order (36C24126N0650), from Veterans Integrated Service Network 1 (VHA), on June 17, 2026.
On GovTribe
See Veracyte Labs SD Corporation's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors